BSX
Price
$97.87
Change
+$0.99 (+1.02%)
Updated
Nov 24, 02:25 PM (EDT)
Capitalization
143.62B
72 days until earnings call
Intraday BUY SELL Signals
ZBH
Price
$92.18
Change
+$3.11 (+3.49%)
Updated
Nov 21 closing price
Capitalization
18.27B
73 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

BSX vs ZBH

Header iconBSX vs ZBH Comparison
Open Charts BSX vs ZBHBanner chart's image
Boston Scientific
Price$97.87
Change+$0.99 (+1.02%)
Volume$800
Capitalization143.62B
Zimmer Biomet Holdings
Price$92.18
Change+$3.11 (+3.49%)
Volume$2.55M
Capitalization18.27B
BSX vs ZBH Comparison Chart in %
BSX
Daily Signal:
Gain/Loss:
ZBH
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
BSX vs. ZBH commentary
Nov 24, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BSX is a Hold and ZBH is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 24, 2025
Stock price -- (BSX: $96.88 vs. ZBH: $92.18)
Brand notoriety: BSX: Notable vs. ZBH: Not notable
Both companies represent the Medical/Nursing Services industry
Current volume relative to the 65-day Moving Average: BSX: 138% vs. ZBH: 140%
Market capitalization -- BSX: $143.62B vs. ZBH: $18.27B
BSX [@Medical/Nursing Services] is valued at $143.62B. ZBH’s [@Medical/Nursing Services] market capitalization is $18.27B. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $222.77B to $0. The average market capitalization across the [@Medical/Nursing Services] industry is $5.63B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BSX’s FA Score shows that 1 FA rating(s) are green whileZBH’s FA Score has 2 green FA rating(s).

  • BSX’s FA Score: 1 green, 4 red.
  • ZBH’s FA Score: 2 green, 3 red.
According to our system of comparison, ZBH is a better buy in the long-term than BSX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BSX’s TA Score shows that 4 TA indicator(s) are bullish while ZBH’s TA Score has 5 bullish TA indicator(s).

  • BSX’s TA Score: 4 bullish, 6 bearish.
  • ZBH’s TA Score: 5 bullish, 6 bearish.
According to our system of comparison, BSX is a better buy in the short-term than ZBH.

Price Growth

BSX (@Medical/Nursing Services) experienced а -5.66% price change this week, while ZBH (@Medical/Nursing Services) price change was +2.52% for the same time period.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was +1.92%. For the same industry, the average monthly price growth was -4.56%, and the average quarterly price growth was +11.92%.

Reported Earning Dates

BSX is expected to report earnings on Feb 04, 2026.

ZBH is expected to report earnings on Feb 05, 2026.

Industries' Descriptions

@Medical/Nursing Services (+1.92% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BSX($144B) has a higher market cap than ZBH($18.3B). BSX has higher P/E ratio than ZBH: BSX (51.81) vs ZBH (22.87). BSX YTD gains are higher at: 8.464 vs. ZBH (-12.105). BSX has higher annual earnings (EBITDA): 4.65B vs. ZBH (2.28B). ZBH has less debt than BSX: ZBH (7.57B) vs BSX (12B). BSX has higher revenues than ZBH: BSX (18.5B) vs ZBH (7.83B).
BSXZBHBSX / ZBH
Capitalization144B18.3B787%
EBITDA4.65B2.28B204%
Gain YTD8.464-12.105-70%
P/E Ratio51.8122.87226%
Revenue18.5B7.83B236%
Total Cash534MN/A-
Total Debt12B7.57B158%
FUNDAMENTALS RATINGS
BSX vs ZBH: Fundamental Ratings
BSX
ZBH
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
79
Overvalued
20
Undervalued
PROFIT vs RISK RATING
1..100
6100
SMR RATING
1..100
6176
PRICE GROWTH RATING
1..100
6163
P/E GROWTH RATING
1..100
8029
SEASONALITY SCORE
1..100
1665

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ZBH's Valuation (20) in the Medical Specialties industry is somewhat better than the same rating for BSX (79). This means that ZBH’s stock grew somewhat faster than BSX’s over the last 12 months.

BSX's Profit vs Risk Rating (6) in the Medical Specialties industry is significantly better than the same rating for ZBH (100). This means that BSX’s stock grew significantly faster than ZBH’s over the last 12 months.

BSX's SMR Rating (61) in the Medical Specialties industry is in the same range as ZBH (76). This means that BSX’s stock grew similarly to ZBH’s over the last 12 months.

BSX's Price Growth Rating (61) in the Medical Specialties industry is in the same range as ZBH (63). This means that BSX’s stock grew similarly to ZBH’s over the last 12 months.

ZBH's P/E Growth Rating (29) in the Medical Specialties industry is somewhat better than the same rating for BSX (80). This means that ZBH’s stock grew somewhat faster than BSX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BSXZBH
RSI
ODDS (%)
Bearish Trend 4 days ago
35%
Bullish Trend 4 days ago
44%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
72%
Bearish Trend 4 days ago
62%
Momentum
ODDS (%)
Bearish Trend 4 days ago
47%
Bullish Trend 4 days ago
56%
MACD
ODDS (%)
Bearish Trend 4 days ago
51%
Bullish Trend 4 days ago
61%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
44%
Bullish Trend 4 days ago
59%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
44%
Bearish Trend 4 days ago
57%
Advances
ODDS (%)
Bullish Trend 12 days ago
62%
Bullish Trend 6 days ago
63%
Declines
ODDS (%)
Bearish Trend 5 days ago
46%
Bearish Trend 8 days ago
56%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
38%
Bullish Trend 4 days ago
49%
Aroon
ODDS (%)
Bullish Trend 4 days ago
55%
Bearish Trend 7 days ago
67%
View a ticker or compare two or three
Interact to see
Advertisement
BSX
Daily Signal:
Gain/Loss:
ZBH
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
ICF60.640.71
+1.18%
iShares Select U.S. REIT ETF
BBLB84.530.53
+0.63%
JPMorgan BetaBuilders U.S. TrsBd20+YrETF
FEUZ57.480.35
+0.61%
First Trust Eurozone AlphaDEX® ETF
AGIX33.99-0.10
-0.31%
KraneShares Artfcl Intllgnc and Tech ETF
RFMZ12.69-0.10
-0.78%
RiverNorth Flexible Municipal Income Fund II

ZBH and

Correlation & Price change

A.I.dvisor indicates that over the last year, ZBH has been loosely correlated with HOLX. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if ZBH jumps, then HOLX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ZBH
1D Price
Change %
ZBH100%
+3.49%
HOLX - ZBH
43%
Loosely correlated
+0.32%
IART - ZBH
42%
Loosely correlated
+8.96%
AVNS - ZBH
41%
Loosely correlated
+4.68%
RVTY - ZBH
41%
Loosely correlated
+4.52%
CNMD - ZBH
39%
Loosely correlated
+5.29%
More